U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
VOLAMCABTAGENE DURZIGEDLEUCEL
INN  
Official Name English
ALLOGENEIC T CELLS OBTAINED FROM PERIPHERAL BLOOD BY LEUKAPHERESIS, GENETICALLY MODIFIED BY CRISPR/CAS9 (CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS/CRISPR-ASSOCIATED PROTEIN 9) MEDIATED GENE EDITING CONSISTING OF THREE GUIDE RNAS (GRNAS) I
Preferred Name English
volamcabtagene durzigedleucel [INN]
Common Name English
Code System Code Type Description
FDA UNII
S5TX5E9EWP
Created by admin on Wed Apr 02 11:07:01 GMT 2025 , Edited by admin on Wed Apr 02 11:07:01 GMT 2025
PRIMARY
NCI_THESAURUS
C203062
Created by admin on Wed Apr 02 11:07:01 GMT 2025 , Edited by admin on Wed Apr 02 11:07:01 GMT 2025
PRIMARY
SMS_ID
300000020591
Created by admin on Wed Apr 02 11:07:01 GMT 2025 , Edited by admin on Wed Apr 02 11:07:01 GMT 2025
PRIMARY
INN
12102
Created by admin on Wed Apr 02 11:07:01 GMT 2025 , Edited by admin on Wed Apr 02 11:07:01 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966